HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 454623Generated: October 27, 2026
Citric Acid → Tert-butyl 4-(2-(2-(benzyloxy)-5-((1-(tert-butoxycarbonyl)piperidin-4-yl)oxy)benzamido)-4-phenylbenzoyloxy)piperidine-1-carboxylate
https://huagongshe.com/reaction/454623
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Citric Acid | HCID 311 | — |
| Reactant | 1,10-Phenanthroline | HCID 1318 | — |
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | Tert-butyl 4-hydroxypiperidine-1-carboxylate | HCID 643502 | — |
| Reactant | Tert-butyl 2-(2-(benzyloxy)-5-iodobenzamido)-4-phenylbenzoate | HCID 66990274 | — |
| Catalyst | Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI) | HCID 24350 | — |
| Solvent | Toluene | HCID 1140 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | Tert-butyl 4-(2-(2-(benzyloxy)-5-((1-(tert-butoxycarbonyl)piperidin-4-yl)oxy)benzamido)-4-phenylbenzoyloxy)piperidine-1-carboxylate | HCID 66990014 | — |
Reaction Steps
1-(tert-Butoxycarbonyl)-4-hydroxypiperidine (0.047 g), cesium carbonate (0.075 g), 1,10-phenanthroline (4.2 mg), and copper(I) iodide (2.2 mg) were added to a toluene (1 mL) solution of tert-butyl 2-(2-(benzyloxy)-5-iodobenzamido)-4-phenylbenzoate (0.070 g), followed by heating to reflux under a nitrogen atmosphere for 4 hours. The reaction mixture was cooled to room temperature, and then 1-(tert-butoxycarbonyl)-4-hydroxypiperidine (0.047 g), cesium carbonate (0.075 g), 1,10-phenanthroline (4.2 mg), and copper(I) iodide (2.2 mg) were added to the reaction mixture, followed by heating to reflux under a nitrogen atmosphere for 2 hours. The reaction mixture was cooled to room temperature, and then 1,10-phenanthroline (4.2 mg) and copper(I) iodide (2.2 mg) were added to the reaction mixture, followed by heating to reflux under a nitrogen atmosphere for 5 hours and 30 minutes. The reaction mixture was cooled to room temperature, and then a 10% aqueous solution of citric acid and ethyl acetate were added thereto. The insoluble substance was removed by filtration. The organic layer was separated, washed with a saturated aqueous solution of sodium chloride, and dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The obtained residue was purified by silica gel column chromatography [Kanto Chemical Co., Inc., silica gel 60 (spherical), eluent: 95-60% hexane/ethyl acetate] to obtain 0.074 g of tert-butyl 4-(2-(2-(benzyloxy)-5-((1-(tert-butoxycarbonyl)piperidin-4-yl)oxy)benzamido)-4-phenylbenzoyloxy)piperidine-1-carboxylate.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08492582B2 |
|---|
| Source dataset | uspto-grants-2013_07 |
|---|
| ORD ID | ord-eccded8063ff4e68a7f69c0abf9eb0b4 |
|---|
| Source note | uspto-grants-2013_07 |
|---|